Potentiation of L-DOPA induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase
dc.contributor.author | Katz, Richard J. | en_US |
dc.contributor.author | Gelbart, Jerry | en_US |
dc.contributor.author | Carroll, Bernard J. | en_US |
dc.date.accessioned | 2006-04-07T17:28:34Z | |
dc.date.available | 2006-04-07T17:28:34Z | |
dc.date.issued | 1980 | en_US |
dc.identifier.citation | Katz, Richard J., Gelbart, Jerry, Carroll, Bernard J. (1980)."Potentiation of L-DOPA induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase." Progress in Neuro-Psychopharmacology 4(1): 101-105. <http://hdl.handle.net/2027.42/23367> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B73FH-4CVPW2Y-D/2/9953cec0d51c08cb69ca910c8ab6ec20 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/23367 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7190718&dopt=citation | en_US |
dc.description.abstract | 1. 1. Pharmacological inhibition of phenylethanolamine-N-methyltransferase (PNMT), the synthesizing enzyme for adrenaline, resulted in enhanced behavioral activation by 3,4,-dihydroxyphenylalanine (L-DOPA) in mice.2. 2. This suggests that an adrenergic system normally inhibits drug induced activation and3. 3. Points to an interaction between adrenaline and other catecholamines. | en_US |
dc.format.extent | 319202 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Potentiation of L-DOPA induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry The University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry The University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.contributor.affiliationum | Mental Health Research Institute, Department of Psychiatry The University of Michigan Medical Center, Ann Arbor, MI 48109, USA | en_US |
dc.identifier.pmid | 7190718 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/23367/1/0000311.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0364-7722(80)90066-1 | en_US |
dc.identifier.source | Progress in Neuro-Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.